Novo Nordisk, manufacturer of Ozempic and Wegovy, is on the Stock Exchange after his results: what do analysts think about his future?

The Danish pharmaceutical company Novo Nordisk, manufacturer of the antidiabetic medicine Ozempic —popularly used to lose weight — and Wegovy against obesity, begins in 2025 on a good footing. The company has presented results of the first trimester above what was anticipated by analysts, although Wegovy's sales have been short on estimates. Following the publication of its net profit, the company's shares rise by about 6% in Copenhagen, the hig…